Author

B. Ganneru

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

A. Shete· 2 shared P. Abraham· 2 shared P. Yadav· 2 shared S. Mohandas· 2 shared A. Awasthi· 1 shared A. Basu· 1 shared A. Kumar· 1 shared D. Kumar· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Shete

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Protective efficacy of COVAXIN(R) against Delta and Omicron variants in hamster model

P. Yadav, S. Mohandas, A. Shete, G. Sapkal, G. Deshpande, A. Kumar, K. Wakchaure, H. Dighe, R. Jain, B. Ganneru, J. Yemul, P. Gawande, K. M. Vadrevu, P. Abraham

This study evaluates COVAXIN's protective efficacy against Delta and Omicron variants in hamsters, showing improved protection with a third dose and reduced disease severity.

bioRxiv · Jun 14, 2022Immunology

Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion Inactivated SARS-CoV-2 Vaccine - BBV152

B. Ganneru, H. Jogdand, V. K. Dharam, N. Reddy, S. D. Prasad, S. Vellimudu, K. M. Ella, R. Ravikrishnan, A. Awasthi, J. Jose, P. Rao, D. Kumar, R. Ella, P. Abraham, P. Yadav, , K. V. Mohan

This study evaluates the safety and immunogenicity of a SARS-CoV-2 vaccine BBV152 in mice, rats, and rabbits, showing high antibody titers and Th1-biased responses with the TLR7/8 agonist adjuvant.

bioRxiv · Sep 9, 2020 · PreprintImmunology